Athens, Greece

Theodosia Maina-Nock

This inventor holds 7 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Advanced Accelerator Applications International Sa, Advanced Accelerator Applications USA, Inc., Other. Active years: 2017-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Theodosia Maina-Nock. Retrieved from https://idiyas.com/inventor/theodosia-maina-nock

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Theodosia Maina-Nock: Innovator in Cancer Diagnostics and Treatment

Introduction

Theodosia Maina-Nock is a prominent inventor based in Athens, Greece. She has made significant contributions to the field of cancer diagnostics and treatment, holding a total of seven patents. Her work focuses on innovative approaches to detecting and treating cancers that express the gastrin-releasing peptide receptor (GRPR).

Latest Patents

Among her latest patents is the invention titled "Radiolabeled GRPR-antagonists for diagnostic imaging and treatment of GRPR-positive cancer." This invention relates to probes designed for the detection, imaging, diagnosis, targeting, and treatment of cancers that express GRPR. These probes may consist of molecules conjugated to detectable labels, which are suitable for detection through various imaging methods, including gamma imaging, SPECT, positron emission tomography (PET), magnetic resonance imaging (MRI), fluorescence spectroscopy, and optical imaging techniques.

Career Highlights

Theodosia has worked with notable companies, including Advanced Accelerator Applications International S.A. Her career is marked by her dedication to advancing cancer treatment technologies and improving patient outcomes through innovative research.

Collaborations

Throughout her career, Theodosia has collaborated with esteemed colleagues, including Berthold Artur Nock and Marion De Jong Hendriks. These collaborations have further enriched her research and contributed to her success in the field.

Conclusion

Theodosia Maina-Nock is a trailblazer in the realm of cancer diagnostics and treatment, with a strong portfolio of patents that reflect her innovative spirit. Her work continues to pave the way for advancements in medical technology and cancer care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…